Emerging risks | Growth Opportunities | APAC Insurance

Thursday, November 12, 2026

Brokerage, Industry M&A, News, Non-life, Private Equity, Strategy

Analysts back A$7.7bn Steadfast takeover on valuation and structural rationale

Strong strategic backing and softer sector valuations are supporting analyst confidence in the Steadfast takeover bid.

By

Gloria Methri

June 17, 2026

•

3 min read

(Re)in AsiaSIRC 2026 Hub

(Re)in AsiaSIRC 2026HubExplore the hub →

Unlock this insight for free

Register for a free 14-day trial to read the full insight.

14 days of access to (Re)in Asia’s premium intelligence
Free daily briefing in your inbox each morning
No credit card required

Already have an account? Sign in →

(Re)in AsiaSIRC 2026 Hub

(Re)in AsiaSIRC 2026HubExplore the hub →

Read next

Steadfast shareholders to vote on A$7.7bn takeover in November October 23 2026
Steadfast inks A$7.7bn takeover deal with Amwins-Dragoneer-KKR consortium August 21 2026
Steadfast trading halted as consortium finalises A$7.7bn deal documentation August 21 2026
Steadfast takeover bid enters final due diligence stage as exclusivity extended August 17 2026
Sagar Balkavde joins PNB MetLife in valuation and reinsurance role October 12 2026
SBI Life’s H1 FY2027 VNB rises 19% to ₹32.7bn October 28 2026